Hepatitis Cis a liver infection due to thehepatitis C virus (HCV).

For some people, HCV infection only causes short-term illness.

Today, DAAs offer cure rates of more than 90%.

Woman considers costs for hepatitis C treatment

Deepak Sethi / Getty Images

Even so, the drugs are extremely costly.

Interferon-alfa had a cure rate of only 6%.

Each is taken by mouth, some with food and others either with or without food.

The Hepatitis C virus.

One of the most notable features of all DAAs is their price.

They are all costly.

This will help determine which DAA is the best fit for you as an individual.

Person with itchy skin problem

In certain cases, ribavirin may also be prescribed.

The different DAA drugs work in unique ways to prevent HCV from making copies of itself.

The treatment can be considered successful,and the infection can be considered cured.

Woman considers costs for hepatitis C treatment

This doesn’t mean you should give up or wait until your condition gets worse before trying again.

Generally, incomes that fall at or below 500% of the FPL qualify.

Discounts can vary, but it is not uncommon to reap savings of 30% or more.

Drug injection is a common way hepatitis C is transmitted

Discount Card Benefits

The benefit of drug discount cards is that there are no eligibility requirements.

You simply print out the discount card or download it onto your smartphone.

Some studies even pay their participants.

By participating in a clinical trial, you may benefit from the latest advances in medical science.

A Word From Verywell

Hepatitis C is more common than many people imagine.

Yes, insurance can cover hepatitis C treatment, although copay or coinsurance costs can vary by the insurer.

On top of this, requests for treatment are sometimes denied, particularly for economically disadvantaged people on Medicaid.

Black people in the United States are disproportionately affected by hepatitis C insurance claim denials.

Department of Health and Human Services.Hepatitis C basic information.

Henry B.Drug pricing & challenges to hepatitis C treatment access.J Health Biomed Law.

doi:10.1093/ofid/ofaa569

Department of Veteran Affairs.Hepatitis C medications: An overview for patients.

doi:10.1177/0033354920904608

Kaiser Family Foundation.Claims denials and appeals in ACA marketplace plans.

Department of Health and Human Services.Viral hepatitis in the United States: Data and trends.

RR-2):117. doi:10.15585/mmwr.rr6902a1

OptumRx.Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) first-time generics.